C09997867 / invoice 10000
Species:CANINE
Breed:Labrador
Age (years):0
Diagnosis or signs:Glimepiride ingestion
Consult notes
Animal clinical history (3 most recent)
2026-03-06T00:00:00Z 11:35 AM
Reason: Has Eaten Diabetes MedicationHISTORY: Mallow ingested 1.5 tablets of 2mg Glimepiride at 09:30 this morning.Mallow has been bright, alert, and responsive (BAR) and acting normally since ingestion.No vomiting, collapse, or abnormal quietness reported.Current meds: noneVaccination: Up to dateParasite Prevention: Not mentionedPre-existing conditions: noneAccess to toxins eg. Rodenticide: Glimepiride 3.5mg (0.16mg/kg) @ 0930EXAMINATION:Body Condition Score: 6/9Pain Scale (0-4): 0/4Hydration status (%): hydration clinically adequateCardiovascular: HR 120 bpm, cardiac auscultation normal, normal rhythm, pulse pressures normal and synchronousRespiratory: thoracic auscultation clear sounds bilaterally, respiratory effort normal, no nasal dischargeNeurological: neurologically no significant findingsMusculoskeletal: ambulating normally, no palpable neck, spine, limb or joint painGastrointestinal:- Oral: normal, no mouth pain, dental score (1-4): Gr 1- Abdominal: no detectable pain on abdominal palpation- Rectal: not performedUrinary: NSFReproductive: NSFIntegument/Ears: NSFLymph Nodes: peripheral lymph nodes within normal limitsEyes: NSFDemeanour/Behaviour: very BAR, bouncy, puffyPROBLEM LIST:Glimepiride ingestion 0.16mg/kgDIFFERENTIAL DIAGNOSIS/ DIAGNOSIS:Concern for hypoglycaemia following glimepiride ingestion.DIAGNOSTICS:Blood glucose: - 11:00 - 5.8 mmol/L - 1330 - 5.0 mmol/L - 1600 - 6.0 mmol/LASSESSMENT:Concern for hypoglycaemia following glimepiride ingestion. Emesis not induced given rapid absorption of medication. Animal Poisons Hotline contacted - no previous cases of this medication intoxication reported. Pharmacist consultation advised monitoring given 24-hour duration of action. Literature suggests hypoglycaemic episodes typically occur after exercise in humans.TREATMENT: Nil indicated at this time.Observations and blood glucose monitoring every 4 hours recommended.PLAN:Hospitalisation and transfer to emergency overnight for observation - owner has elected JCU. Blood glucose monitoring every 4 hours.Keep quiet to minimise exercise-induced hypoglycaemia risk.CLIENT COMMUNICATION:Owner to transfer Mallow to JCU for overnight monitoring.Owner will collect Mallow at 16:00.Ate 140g G/Int tin (126kcal)Verbal handover to JCU Vet @ 1430 - Dr Jaime Ridley. Estimate of <$500 given unless any episodes of hypoglycemia noted.Laboratory: Type: Test: Results:--- 06/03/2026 14:39:25: Emailed JCU full history. JK Vital Signs Weight: 25.5;
Previous claim history (2)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-01-09 | C09736102 | HIP DYSPLASIA, DEVELOPMENTAL |
| 2026-01-09 | C09736102 | EAR INFECTION |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_hospitalisation | 109.87 | 2026-03-06 | — |
| 20000 | tstarc_anaesthesia_-_inhalation_anaesthetic | 150.00 | 2026-03-06 | — |
| 30000 | tstarc_diagnostic_test_-_glucose | 3.70 | 2026-03-06 | — |
| 40000 | tstarc_diagnostic_test_-_glucose | 17.81 | 2026-03-06 | — |
| 50000 | tstarc_diagnostic_test_-_glucose | 20.70 | 2026-03-06 | — |
| 60000 | tstarc_diagnostic_test_-_glucose | 3.70 | 2026-03-06 | — |
| 70000 | tstarc_diagnostic_test_-_glucose | 17.90 | 2026-03-06 | — |
| 80000 | tstarc_diagnostic_test_-_glucose | 20.70 | 2026-03-06 | — |
| 90000 | tstarc_diagnostic_test_-_glucose | 3.70 | 2026-03-06 | — |
| 100000 | tstarc_diagnostic_test_-_glucose | 17.90 | 2026-03-06 | — |
| 110000 | tstarc_diagnostic_test_-_glucose | 20.72 | 2026-03-06 | — |
UPM+
- DG02444INTOXICATION (POISONING), DRUG - ACCIDENTAL THERAPEUTIC DRUG OVERDOSEDSTP_toxicity_-_medications_or_drugs
Variant (sleepy_king)
INTOXICATION (POISONING)/TOXIN EXPOSURE - PRESENTING COMPLAINT
DSTP_toxicity_-_unspecified
Conf: 0.920
Threshold: 0.21
Above: ✓
Correct?
Reason (correct)